Floatz logo

Acetazolamide

Obesity-induced Hyperfiltration

Rabin Medical CenterSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Obesity-induced Hyperfiltration cohort.

Asset / SponsorPhaseRating
FUROSEMIDE
Rabin Medical Center
N/AD
AMINOHIPPURIC ACID, P-
Rabin Medical Center
N/AD
LITHIUM, ELEMENTAL
Rabin Medical Center
N/AD
Inulin
Rabin Medical Center
N/AD

Same molecule, other indications

Acetazolamide is also rated in:

Obstructive Sleep ApneaDormant
BB
Indicative ·
67 / 100
View asset →
Metabolic AlkalosisDormant
B
Indicative ·
60 / 100
View asset →
Obesity Hypoventilation SyndromeDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →